Ubichem Approved for cGMP Radiolabelled API Production
Ubichem through its Hungarian operation - Ubichem Research - has successfully completed a regulatory inspection and is now approved for the supply of cGMP radiolabelled active pharmaceutical ingredients (APIs).
Jozsef Repasi, Managing Director of Ubichem Research commented: “This approval enables us to supply radiolabelled materials for use in human clinical trials, and is a reflection of the skill and hard work of our dedicated team in Budapest, building on the approval obtained previously for the commercial supply of cGMP APIs.”
Other news from the department politics & laws

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
Pan_American_Health_Organization
SOLVO Biotechnology and KRISHGEN BioSystems announced a Distribution and Service Representation Agreement

SOLVO Biotechnology has received the ISO 9001:2000 Quality Management System Certification
Richard_Gordon_(author)
Alzheimer's disease risk linked to a network of genes associated with myeloid cells
